Synthetic cannabinoids
Open accessAbstract
Synthetic cannabinoids are a large family of chemically unrelated compounds functionally similar to delta-9-tetrahydrocannabinol (THC), the active component of Cannabis sativa .1,2 However, synthetic cannabinoids are not derived from cannabis and, unlike THC, are full agonists at cannabinoid
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Nabilone will not give a positive urine test for THC and therefore may be used to ensure that nabilone-treated patients are not also using cannabis.
“Nabilone will not give a positive urine test for THC and therefore may be used to ensure that nabilone-treated patients are not also using cannabis.35,36”
From Nabilone for the Management of Pain (2016) · cites this paper as [35]
The “Diagnosis requires a high index of suspicion” section says synthetic cannabinoids are not detected by urine immunoassay tests for THC. It does not name nabilone or discuss using THC tests to monitor cannabis use in nabilone-treated patients, so those specifics are not established by this paper. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cited by
Sorted by citations
Nabilone for the Management of Pain
Tsang, C. C., & Giudice, M. G. (2016) · Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.1709 · Cited by 73 · see citing works
- Authors
- Antoniou, T., & Juurlink, D. N.
- Affiliations
- St. Michael's Hospital (CA)
- Venue
- Canadian Medical Association Journal
- Publisher
- CMA Impact Inc.
- Published
- 2013-10-07
- Volume
- 186
- Issue
- 3
- Pages
- 210-210
- ISSN
- 0820-3946 (ISSN-L)
- 1488-2329
- PMC
- PMC3928213
- OpenAlex
- W4237437899
- Cited by
- 29
- References
- 0
- Citations by year
- 2026: 1 · 2025: 1 · 2024: 6 · 2023: 2 · 2022: 1 · 2021: 3 · 2020: 3 · 2019: 2 · 2017: 3 · 2016: 3 · 2015: 4
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- Canadian Medical Association Journal (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Health Sciences › Medicine › Emergency Medicine › Poisoning and overdose treatments
- Keywords
- synthetic cannabinoids, delta-9-tetrahydrocannabinol, cannabinoid receptor agonists, Cannabis sativa, cannabis-derived compounds
- MeSH terms
- Cannabinoids, Humans, Designer Drugs
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
